News
A Significant Step Toward Greater Clarity in Polymorph Control for Innovative Drugs
28 Jan 2026
en
In a world where technology, regulations, and therapeutic modalities evolve by the month, how do biotech teams stay ahead? We' re here to help.
From small molecules to biologics and nucleic acid therapeutics, Crystal Pharmatech supports phase-appropriate CMC strategy, integrated analytical/bioanaltical solutions, and scalable development pathways that keep programs moving toward First-in-Human and beyond—with speed, quality, and clarity.
Book a meeting: contact@crystalpharmatech.com
Alex Chen, Ph.D.
Co-founder & CEO
Crystal Pharmatech
Yongqiang Li, Ph.D.
CEO of Canada CDMO BU
Candoo Pharmatech
When: October 28-30, 2025
Where: Messe Frankfurt, Frankfurt, Germany
Find Us: Booth #4.1 C62
Ready for an evening of unscripted connection?
Please complete the form to register for our San Diego Biotech and Pharma R&D social. Note: Registration is subject to review. You will receive a formal confirmation email once your attendance is approved.
By providing your e-mail address, you agree to receive an e-mail response from Crystal Pharmatech to your registration. The information you submit will be governed by our Privacy Policy.
_.webp "A Significant Step Toward Greater Clarity in Polymorph Control for Innovative Drugs")
Subscribe to be the first to get the updates!
